Synopsis of recent research by authors named "Niklas Vesper"
- Niklas Vesper's research primarily focuses on peptide therapeutics and the development of innovative assays for immune response evaluation, particularly in the context of SARS-CoV-2 and B cell activation.
- His work includes the creation of finDr, a web server designed to identify D-peptide ligands, which are advantageous due to their stability and resilience against degradation, thereby improving pharmacokinetic profiles.
- Vesper has also contributed to the understanding of immune responses to SARS-CoV-2 by developing a barcoded flow cytometric assay to explore antibody responses against the virus and a surrogate cell-based blocking assay to assess neutralizing antibody titers efficiently.
